Identification of CSRP1 As Novel Biomarker for Hormone-Sensitive Prostate Cancer by the Combination of Clinical and Functional Research

The authors employed a multiomics approach involving bioinformatics analysis on datasets GSE2443 and GSE35988, along with proteomics studies, to discover that cysteine- and glycine-rich protein 1 (CSRP1) expression significantly impacted the progression of hormone-sensitive prostate cancer.